Letters
Reply
Weiyang Tao,
Timothy R. D. J. Radstake,
Aridaman Pandit,
Weiyang Tao
University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
Search for more papers by this authorTimothy R. D. J. Radstake
University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands and AbbVie, Chicago, IL
Search for more papers by this authorCorresponding Author
Aridaman Pandit
University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
Search for more papers by this authorWeiyang Tao,
Timothy R. D. J. Radstake,
Aridaman Pandit,
Weiyang Tao
University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
Search for more papers by this authorTimothy R. D. J. Radstake
University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands and AbbVie, Chicago, IL
Search for more papers by this authorCorresponding Author
Aridaman Pandit
University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
Search for more papers by this authorFirst published: 07 March 2021
No abstract is available for this article.
References
- 1Mellors T, Withers JB, Ameli A, Jones A, Wang M, Zhang L, et al. Clinical validation of a blood-based predictive test for stratification of response to tumor necrosis factor inhibitor therapies in rheumatoid arthritis patients. Netw Syst Med 2020; 3: 91–104.
10.1089/nsm.2020.0007 Google Scholar
- 2Bienkowska JR, Dalgin GS, Batliwalla F, Allaire N, Roubenoff R, Gregersen PK, et al. Convergent Random Forest predictor: methodology for predicting drug response from genome-scale data applied to anti-TNF response. Genomics 2009; 94: 423–32.
- 3Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness [review]. Health Technol Assess 2006; 10: 1–229.
- 4Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 2016; 68: 1–26.
